Zobrazeno 1 - 10
of 47
pro vyhledávání: '"K Arévalo Ruales"'
Publikováno v:
Zeitschrift Fur Rheumatologie
Zeitschrift für Rheumatologie
Zeitschrift für Rheumatologie
The article describes the case of a hospitalized 58-year-old female patient with a chronic dry cough and increased inflammation values. Before hospital admission, the presence of coronavirus disease 2019 (COVID-19) was excluded by a normal chest X‑
Autor:
J. Ivorra Cortés, I. Martínez Cordellat, R. Gonzalez Mazario, JE Oller Rodriguez, E. Calabuig Muñoz, V. Fornes Ferrer, M. Tasias Pitarch, C. Alcañiz Escandell, L. González Puig, C. Feced Olmos, C.V. Inmaculada, J. Fragio, E. Labrador Sánchez, F.M. Ortiz Sanjuan, M. De la Rubia Navarro, JA Román Ivorra, K. Arévalo Ruales, E. Grau Garcia, I Cánovas Olmos, C. Nájera Herranz, M Salavert Lletí, R. Negueroles Albuixech
Publikováno v:
Saturday, 16 JUNE 2018.
Background Spondylodiscitis is an infectious disease of the vertebral body and intervertebral space, the early diagnosis and treatment are essential to give the patient the best chance of a good outcome, but these are often delayed because it tends t
Autor:
R. Gonzalez Mazario, J. Ivorra Cortés, I. Martínez Cordellat, C. Alcañiz Escandell, A. Alba Redondo, F.M. Ortiz Sanjuan, C. Nájera Herranz, I Cánovas Olmos, R. Negueroles Albuixech, E. Vicens Bernabeu, L. González Puig, A. J. Cañada Martinez, M. De la Rubia Navarro, JJ Fragio Gil, C. Feced Olmos, K. Arévalo Ruales, I. Chalmeta Verdejo, JA Román Ivorra, P. Jover Carbonell, M. L. Martínez Triguero, JE Oller Rodriguez, E. Labrador Sánchez, E. Grau Garcia
Publikováno v:
Other orphan diseases.
Background The mixed connective tissue disease (MCTD) is an autoimmune systemic disease characterised by clinical manifestations that are included in systemic lupus erythematous (SLE), scleroderma (SSc) or rheumatoid arthritis (RA). Moreover the MCTD
Autor:
I. Martínez Cordellat, I Cánovas Olmos, JA Román Ivorra, C. Alcañiz Escandell, E. Labrador Sánchez, F.M. Ortiz Sanjuan, E. Grau Garcia, J. Ivorra Cortés, R. Negueroles Albuixech, R. Gonzalez Mazario, C. Feced Olmos, M. De la Rubia Navarro, JJ Fragio Gil, I. Chalmeta Verdejo, K. Arévalo Ruales, C. Nájera Herranz, JE Oller Rodriguez, E. Vicens Bernabeu, L. González Puig
Publikováno v:
Scleroderma, myositis and related syndromes.
Background Raynaud’s phenomenon (RP) is frequently associated with the presence of scleroderma or other connective tissue diseases (CTD). Identify the presence of secondary RP is important to perform an adequate therapeutic management and to achiev
Autor:
E. Labrador Sánchez, V. Fornes Ferrer, I Cánovas Olmos, JA Castellano Cuesta, C. Feced Olmos, E. Vicens Bernabeu, D. Hervás Marín, C. Nájera Herranz, R. Negueroles Albuixech, L. González Puig, C. Alcañiz Escandell, M. Fernández Matilla, I. Martínez Cordellat, J. Ivorra Cortés, JA Román Ivorra, M. De la Rubia Navarro, K. Arévalo Ruales, JJ Fragio Gil, JE Oller Rodriguez, N Fernandez-Llanio Cornella, R. Gonzalez Mazario, I. Chalmeta Verdejo, F.M. Ortiz Sanjuan, Elia Grau
Publikováno v:
Poster session 2: Autoantibodies, biomarkers and imaging (2), Environmental, epigenetics and genomics.
Purpose The aim of this study is to assess the clinical and molecular differences in SLE patients with positives autoantibodies and with low clinical activity or in clinical remission compared to the group with clinical activity. Methods A cross-sect
Autor:
I Cánovas Olmos, S Cerda Checa, K. Arévalo Ruales, R. Gonzalez Mazario, C. Alcañiz Escandell, E. Vicens Bernabeu, L. González Puig, R. Negueroles Albuixech, JE Oller Rodriguez, M. De la Rubia Navarro, JJ Fragio Gil, I. Chalmeta Verdejo, F.M. Ortiz Sanjuan, I. Martínez Cordellat, J. Ivorra Cortés, C. Nájera Herranz, JA Román Ivorra, C. Feced Olmos, E. Labrador Sánchez, E. Grau Garcia
Publikováno v:
Poster session 7: New drugs and trageted therapy.
Purpose To study the clinical safety and adverse events (AEs) of Belimumab treatment in routine clinical practice in SLE patients. Methods Retrospective observational study in which data from patients diagnosed of SLE according to SLICC 2012 criteria
Autor:
V. Fornes Ferrer, D. Hervás Marín, C. Alcañiz Escandell, I. Chalmeta Verdejo, I. Martínez Cordellat, F.M. Ortiz Sanjuan, JE Oller Rodriguez, M. De la Rubia Navarro, JJ Fragio Gil, J. Ivorra Cortés, JA Castellano Cuesta, Elia Grau, R. Negueroles Albuixech, E. Vicens Bernabeu, C. Feced Olmos, K. Arévalo Ruales, L. González Puig, R. Gonzalez Mazario, I Cánovas Olmos, C. Nájera Herranz, N Fernandez-Llanio Cornella, E. Labrador Sánchez, M. Fernández Matilla, JA Román Ivorra
Publikováno v:
Poster session 1: Autoantibodies, biomarkers and imaging (1).
Purpose To analyse the association among INF1A, IL10 and BLyS levels and clinical activity in SLE. Methods A cross-sectional, observational study of 142 patients diagnosed of SLE according to SLICC 2012 criteria and 34 healthy controls was performed.
Autor:
E. Labrador Sánchez, C. Nájera Herranz, V. Fornes Ferrer, E. Vicens Bernabeu, JA Román Ivorra, L. González Puig, M. Fernández Matilla, J. Ivorra Cortés, JA Castellano Cuesta, I. Chalmeta Verdejo, N Fernadez-Llanio Cornella, C. Alcañiz Escandell, D Gimenez-Romero, M. De la Rubia Navarro, JJ Fragio Gil, K. Arévalo Ruales, D. Hervás Marín, C. Feced Olmos, Elia Grau, JE Oller Rodriguez, I. Martínez Cordellat, I Cánovas Olmos, F.M. Ortiz Sanjuan, R. Gonzalez Mazario, R. Negueroles Albuixech
Publikováno v:
Poster session 1: Autoantibodies, biomarkers and imaging (1).
Purpose The aim of the present study is to identify false-negatives for anti-Ro by analysing both 52 KDa and 60 KDa subunits separately, as well as to characterise if there are clinical or molecular differences in this subgroup of patients compared t
Autor:
C. Feced Olmos, JA Román Ivorra, R. Negueroles Albuixech, K. Arévalo Ruales, E. Grau Garcia, C. Nájera Herranz, I. Chalmeta Verdejo, R Nicolás Rodrigo, JJ Fragio Gil, I Cánovas Olmos, R Mazarío González, D Marín Hervás, M. Fernández Matilla, C. Alcañiz Escandell, JE Oller Rodriguez, Francisco Ortiz-Sanjuán, V. Fornes Ferrer, L González Olivares, E. Vicens Bernabeu, L. González Puig, JA Castellano Cuesta, N. Fernández-Llanio, E Sánchez Labrador, I. Martínez Cordellat, J. Ivorra Cortés
Publikováno v:
Poster Presentations.
Background Systemic lupus erythematous (SLE) shows increased DNA demethylation. An intermediate step to DNA demethylation is the DNA hydroxymethylation, where 5-mC is oxidized into 5-hmC. Hydroxymethylation is not completely understood and it may be
Autor:
E Sánchez Labrador, I Cánovas Olmos, C. Alcañiz Escandell, N. Fernández-Llanio, M. Fernández Matilla, D Marín Hervás, C. Nájera Herranz, Francisco Ortiz-Sanjuán, R Mazarío González, K. Arévalo Ruales, E. Vicens Bernabeu, D Gimenez Romero, V. Fornes Ferrer, JA Román Ivorra, I. Chalmeta Verdejo, L. González Puig, R. Negueroles Albuixech, JE Oller Rodriguez, JJ Fragio Gil, C. Feced Olmos, J. Ivorra Cortés, I. Martínez Cordellat, E. Grau Garcia, JA Castellano Cuesta
Publikováno v:
Poster Presentations.
Background Systemic lupus erythematous (SLE) is an autoimmune disease characterized by immune system disruption with autoantibodies production. One of the upregulated autoantibodies is the specific to the Ro antigen, a ribonucleoprotein associated to